InSiGHT Group. Evaluation of CADD scores in curated mismatch repair gene variants yields a model for clinical validation and prioritization.

Maurizio Genuardi, J Kuiper, Ba Thompson, Jp Plazzer, G Van Valkenhoef, M De Haan, Jd Jongbloed, C Wijmenga, Tj De Koning, Km Abbott, R Sinke, Ab Spurdle, F Macrae, M Genuardi, Rh Sijmons, Ma Swertz, Kj Van Der Velde

Risultato della ricerca: Contributo in rivistaArticolo in rivista

27 Citazioni (Scopus)

Abstract

Next generation sequencing in clinical diagnostics is providing valuable genomic variant data, which can be used to support healthcare decisions. In silico tools to predict pathogenicity are crucial to assess such variants and we have evaluated a new tool, Combined Annotation Dependent Depletion (CADD), and its classification of gene variants in Lynch syndrome by using a set of 2210 DNA mismatch repair gene variants. These had already been classified by experts from InSiGHT's Variant Interpretation Committee. Overall, we found CADD scores do predict pathogenicity (Spearman's ρ = 0.595, p ≪ 0.001). However, we discovered 31 major discrepancies between the InSiGHT classification and the CADD scores; these were explained in favor of the expert classification using population allele frequencies, co-segregation analyses, disease association studies, or a second-tier test. Of 751 variants that could not be clinically classified by InSiGHT, CADD indicated that 47 variants were worth further study to confirm their putative pathogenicity. We demonstrate CADD is valuable in prioritizing variants in clinically relevant genes for further assessment by expert classification teams. This article is protected by copyright. All rights reserved.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaHuman Mutation
Stato di pubblicazionePubblicato - 2015

Keywords

  • Lynch syndrome
  • cumulative link model
  • pathogenicity prediction
  • variant classification

Fingerprint Entra nei temi di ricerca di 'InSiGHT Group. Evaluation of CADD scores in curated mismatch repair gene variants yields a model for clinical validation and prioritization.'. Insieme formano una fingerprint unica.

Cita questo